Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

What 4 Analyst Ratings Have To Say About RAPT Therapeutics

Analysts have provided the following ratings for RAPT Therapeutics (NASDAQ:RAPT) within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 4 0 0 0
Last 30D 0 1 0 0 0
1M Ago 0 1 0 0 0
2M Ago 0 0 0 0 0
3M Ago 0 2 0 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for RAPT Therapeutics. The company has an average price target of $45.25 with a high of $55.00 and a low of $30.00.

Below is a summary of how these 4 analysts rated RAPT Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average has decreased by 23.73% from the previous average price target of $59.33.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.